Abstract
While surgery and radiotherapy are widely recognized for their efficacy, chemotherapy and innovative therapies have found only recently their role in the management of pediatric brain tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antonini G et al (2007) Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. J Neurooncol 81(2):197–199. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/16937012
Ashley DM et al (2012) Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children’s Oncology Group study P9934. J Clin Oncol 30(26):3181–3186. Consulté 6 juin 2017 http://ascopubs.org/doi/10.1200/JCO.2010.34.4341
Ater JL et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol 30(21):2641–2647. Consulté 31 déc 2013 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3413276&tool=pmcentrez&rendertype=abstract
Atkinson JM et al (2011) An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell 20(3):384–399. Consulté 8 juillet 2015 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3172881&tool=pmcentrez&rendertype=abstract
Bandopadhayay P et al (2014) BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res 20(4):912–925. Consulté 6 mars 2016 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4198154&tool=pmcentrez&rendertype=abstract
Batchelor TT et al (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11(1):83–95. Consulté 13 déc 2013 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2748664&tool=pmcentrez&rendertype=abstract
Batra V et al (2014) Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 61(1):151–157. Consulté 1 août 2017 http://www.ncbi.nlm.nih.gov/pubmed/24038913
Blakeley J (2008) Drug delivery to brain tumors. Curr Neurol Neurosci Rep 8(3):235–241. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/18541119
Bouffet E et al (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30(12):1358–1363. Consulté 31 déc 2013 http://www.ncbi.nlm.nih.gov/pubmed/22393086
Broniscer A et al (2007) Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. Clin Cancer Res 13(22 Pt 1):6712–6718. Consulté 22 déc 2013 http://www.ncbi.nlm.nih.gov/pubmed/18006772
von Bueren AO et al (2012) Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. Br J Cancer 107(8):1399–1408. Consulté 12 jan 2015 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3494444&tool=pmcentrez&rendertype=abstract
Calaminus G et al (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 15(6):788–796. Consulté 10 nov 2014 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3661100&tool=pmcentrez&rendertype=abstract
Cavalli FMG et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31(6):737–754.e6. Consulté 16 juin 2017 http://www.ncbi.nlm.nih.gov/pubmed/28609654
Chastagner P et al (2015) Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma. Cancer Chemother Pharmacol 76(2):425–432. Consulté 27 avril 2016 http://link.springer.com/10.1007/s00280-015-2781-0
Chinot Olivier L et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709–722 Consulté http://www.nejm.org/doi/full/10.1056/NEJMoa1308345?query=featured_home#t=abstract\nhttp://www.ncbi.nlm.nih.gov/pubmed/24552318
Cloughesy Timothy F et al (2005) Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol 23(27):6647-6656. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/16170172
Cohen Kenneth J et al (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children’s Oncology Group. Neurooncology 13(4):410-416. Consulté 14 mars 2016 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3064697&tool=pmcentrez&rendertype=abstract
Collins VP, Jones DTW, Giannini C (2015) Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129(6):775–788. Consulté 5 avril 2015 http://www.ncbi.nlm.nih.gov/pubmed/25792358
Crone C (1986) The blood-brain barrier as a tight epithelium: where is information lacking? Ann N Y Acad Sci 481:174-185. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/3468856
Das Thakur M, Stuart DD (2014) Molecular pathways: response and resistance to BRAF and MEK inhibitors in BRAF(V600E) tumors. Clin Cancer Res 20(5):1074–1080. Consulté 6 mars 2016 http://www.ncbi.nlm.nih.gov/pubmed/24352648
Duffner PK et al (1999) The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol 1(2):152-161 Consulté 20 nov 2014 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1920752&tool=pmcentrez&rendertype=abstract
Dufour Christelle et al (2014) Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors Pediatr Blood Cancer 61(8):1398-1402. Consulté 15 février 2017 http://www.ncbi.nlm.nih.gov/pubmed/24664937
Emerson DL (2000) Liposomal delivery of camptothecins. Pharma Sci Technol Today 3(6):205-209. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/10840391
Fangusaro Jason et al (2008) Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and I. Pediatr Blood Cancer. 50(2):312-318 Consulté 20 nov 2014 http://www.ncbi.nlm.nih.gov/pubmed/17668858
Faoro Denis et al (2011) Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma. J Neurooncol. 103(1):59-69 Consulté 12 jan 2015 http://www.ncbi.nlm.nih.gov/pubmed/20820873
Gandola L et al (2008) Hyperfractionated accelerated radiotherapy in the milan strategy for metastatic medulloblastoma J Clin Oncol 27(4):566-571. Consulté 13 février 2017 http://www.ncbi.nlm.nih.gov/pubmed/19075266
Gilbert Mark R et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699-708 Consulté http://www.nejm.org/doi/abs/10.1056/NEJMoa1308573
Gokce-Samar Z et al (2016) Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas. Child Nerv Syst 32(8):1415–1423. Consulté 9 jan 2017 http://link.springer.com/10.1007/s00381-016-3153-8
Goldman S et al (2015) Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: a children’s oncology group study. J Clin Oncol 33(22):2464–2471. Consulté 27 juin 2015 http://www.ncbi.nlm.nih.gov/pubmed/26101244
Grill J Kalifa C (1998) High dose chemotherapy for childhood ependymoma. J Neurooncol. 40(1):97 Consulté 30 déc 2014 http://www.ncbi.nlm.nih.gov/pubmed/9874191
Grill J et al (2011) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 58(4):489–491
Groothuis DR (2000) The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neurooncology 2(1):45-59. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/11302254
Gropman AL et al (1998) Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control. Cancer 83(1):166–172. Consulté http://www.ncbi.nlm.nih.gov/pubmed/9655307
Groves MD et al (2008) A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neurooncology 10(2):208–215. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/18316473
Grundy RG et al (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8(8):696–705. Consulté 30 déc 2014 http://www.ncbi.nlm.nih.gov/pubmed/17644039
Gururangan S et al (2012) Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma–a Pediatric Brain Tumor Consortium study. Neurooncology 14(11):1404–1412. Consulté 10 juillet 2015 http://www.ncbi.nlm.nih.gov/pubmed/23019233
Hargrave Darren et al (2013) A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study. J Neurooncol 113(1):127-134. Consulté 18 nov 2014 http://www.ncbi.nlm.nih.gov/pubmed/23459995
Hedley-Whyte ET, Hsu DW (1986) Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol 19(4):373–377. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/3707089
Hovestadt V et al (2014) Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510(7506):537–541. Consulté 26 février 2016 http://www.ncbi.nlm.nih.gov/pubmed/24847876
Jakacki RI et al (2016) Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children’s Oncology Group ACNS0423 study. Neurooncology 18(10):1442–1450. Consulté 29 mars 2016 http://www.ncbi.nlm.nih.gov/pubmed/27006176
Jones DTW et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45(8):927–932. Consulté 4 mars 2015 http://www.ncbi.nlm.nih.gov/pubmed/23817572
Kawauchi D et al (2012) A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21(2):168–180. Consulté 6 mars 2016 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3285412&tool=pmcentrez&rendertype=abstract
Kieran Mark W (2014) Targeting BRAF in pediatric brain tumors. Am Soc Clin Oncol Educ Book. 2014:e436-e440. Consulté 6 mars 2016 http://www.ncbi.nlm.nih.gov/pubmed/24857135
Kool M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123(4):473–484. Consulté 25 oct 2014 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3306778&tool=pmcentrez&rendertype=abstract
Kool M et al (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25(3):393–405. Consulté 15 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/24651015
Kroll RA, Neuwelt EA (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42(5):1083–99, 100. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/9588554
Lannering B et al (2012) Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial. J Clin Oncol 30(26):3187–3193. Consulté 20 déc 2016 http://www.ncbi.nlm.nih.gov/pubmed/22851561
Lee P et al (2015) Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. Anticancer Res 35(2):615–625. Consulté 15 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/25667438
Li G et al (2012) Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas. J Neurooncol 108(3):395–402. Consulté 28 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/22382786
Masoudi A et al (2008) Influence of valproic acid on outcome of high-grade gliomas in children. Anticancer Res 28(4C):2437–2442. Consulté 29 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/18751431
Massimino M et al (2014) Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol 118(2):305–312. Consulté 1 août 2017 http://www.ncbi.nlm.nih.gov/pubmed/24696052
Massimino M et al (2016) Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. Neuro Oncol 18(10):1451–1460. Consulté 20 mai 2016 http://www.ncbi.nlm.nih.gov/pubmed/27194148
Mercurio S et al (2013) Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma. Acta Neuropathol Commun 1:17. Consulté 28 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/24252689
Miller G (2002) Drug targeting. Breaking down barriers. Science (New York, NY) 297(5584):1116–1118. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/12183610
Modak S et al (2004) Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 22(10):1934–1943. Consulté 6 septembre 2015 http://www.ncbi.nlm.nih.gov/pubmed/15143087
Morfouace M et al (2014) Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma. Cancer Cell 25(4):516–529. Consulté 15 février 2016 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3994669&tool=pmcentrez&rendertype=abstract
Muldoon LL et al (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 25(16):2295–2305. Consulté 31 déc 2013 http://www.ncbi.nlm.nih.gov/pubmed/17538176
Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA 79(14):4420–4423. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/6289301
Packer RJ et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81(5):690–698. Consulté 3 février 2017 http://thejns.org/doi/10.3171/jns.1994.81.5.0690
Packer RJ et al (2005) A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Cancer 104(9):1968–1974. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/16177987
Pajtler KW et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728–743. Consulté 13 mai 2015 http://www.ncbi.nlm.nih.gov/pubmed/25965575
Paugh BS et al (2013) Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 73(20):6219–6229. Consulté 9 février 2016 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3800209&tool=pmcentrez&rendertype=abstract
Pérez-Martínez A et al (2005) High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 71(1):33–38. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/15719272
Peyrl A et al (2012) Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors. Pediatr Blood Cancer 59(3):511–517. Consulté 28 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/22147459)
Phi JH et al (2015) Overcoming chemoresistance of pediatric ependymoma by inhibition of STAT3 signaling. Transl Oncol 8(5):376–386. Consulté 2 nov 2015 http://www.ncbi.nlm.nih.gov/pubmed/26500028)
Prados MD et al (2004) Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neurooncology 6(1):44–54. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/14769140
Robinson GW et al (2015) Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase ii pediatric brain tumor consortium studies PBTC-025B and PBTC-032. J Clin Oncol 33(24):2646–2654. Consulté 15 août 2015 http://www.ncbi.nlm.nih.gov/pubmed/26169613
Rubenstein JL et al (2007) Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 25(11):1350–1356. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/17312328
Rubie H et al (2010) Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. Eur J Cancer 46(15):2763–2770
Rutkowski S et al (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10):978–986. Consulté 2 déc 2016 http://www.ncbi.nlm.nih.gov/pubmed/15758008
Salloum R et al (2016) A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study. J Neurooncol 129(3):443–451. Consulté 1 juillet 2016 http://www.ncbi.nlm.nih.gov/pubmed/27350411
Singh SK, Clarke ID, Hide T, Dirks PB (2004) Cancer stem cells in nervous system tumors. Oncogene 23(43):7267–7273. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/15378086
Singh AR et al (2016) PI-3K inhibitors preferentially target CD15+ cancer stem cell population in SHH driven medulloblastoma. PLoS One 11(3):e0150836. Consulté 10 mars 2016 http://www.ncbi.nlm.nih.gov/pubmed/26938241
Straathof CS et al (1998) The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. J Neurooncol 37(1):1-8. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/9525832
Stupp R, Mason WP, Van den Bent MJ, Weller M, et al. (2005) European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med. 352:987–96.
Warren K et al (2006) Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group. Cancer Chemother Pharmacol 58(3):343–347. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/16408203
Wolff JEA et al (2010) Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer 116(3):705–712. Consulté 31 déc 2013 http://www.ncbi.nlm.nih.gov/pubmed/19957326
Wright KD et al (2015) Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma. Neurooncology 17(12):1620–1627. Consulté 21 nov 2015 http://www.ncbi.nlm.nih.gov/pubmed/26541630
Zhao X et al (2015) RAS/MAPK activation drives resistance to Smo inhibition, metastasis, and tumor evolution in shh pathway-dependent tumors. Cancer Res 75(17):3623–3635. Consulté 15 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/26130651
Ziylan YZ, Lefauconnier JM, Bernard G, Bourre JM (1989) Regional alterations in blood-to-brain transfer of alpha-aminoisobutyric acid and sucrose, after chronic administration and withdrawal of dexamethasone. J Neurochem 52(3):684-689. Consulté 14 juin 2016 http://www.ncbi.nlm.nih.gov/pubmed/2918309
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Frappaz, D., Faure-Conter, C. (2020). Pediatric Chemotherapy. In: Di Rocco, C., Pang, D., Rutka, J. (eds) Textbook of Pediatric Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-72168-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-72168-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72167-5
Online ISBN: 978-3-319-72168-2
eBook Packages: MedicineReference Module Medicine